Abstract:The traditional "brain-derived neurotrophic factor (BDNF) hypothesis of depression" proposes that impairment of the BDNF signaling pathway in the hippocampus and prefrontal cortex participates in the pathophysiology of depression, and antidepressants act by recovering/enhancing BDNF signal transduction. Recent studies have suggested that BDNF signaling pathways exert more diverse and complex effects on depression onset and antidepressant therapy than originally thought, which include: (1) inhibition of the BDNF-TrkB signaling pathway in the hippocampus and/or prefrontal cortex does not induce the depression-like behavioral phenotype, but significantly diminishes therapeutic effects, which suggests that the BDNF-TrkB signaling pathway lacks direct or key effects on occurrence of emotional disorders, whereas an intact and normal BDNF-TrkB signaling pathway is necessary for antidepressant therapy. (2) The BDNF-TrkB signaling pathway exhibits opposite regulatory effects on depressive behavior in the hippocampus-prefrontal cortex network and mesolimbic system, which suggests that BDNF regulates emotion by affecting the emotion-related neural network, but not a single brain region. (3) The BDNF-TrkB and proBDNF-p75(NTR) signaling pathways in the brain, respectively, enhance and suppress hippocampal neural plasticity, which demonstrated that different BDNF signaling pathways interact and restrict each other in the regulation of neural plasticity and emotional behaviors. (4) BDNF gene polymorphism might be associated with susceptibility to depression. These new findings extend our understanding of neuronal pathways and mechanisms of action of BDNF signaling and contribute to improved views to traditional "neurotrophic factor hypothesis of depression".

Research Progress of BDNF and Depression

Exploring the Association between BDNF related Signaling Pathways and Depression: A Literature Review

Progress in the "Brain-Derived Neurotrophic Factor Hypothesis of Depression"

Neurotrophic basis to the pathogenesis of depression and phytotherapy

Research Progress of Bipolar Disorder and Signaling Pathway of Brain Derived Neurotrophic Factor

The role of brain derived neurotrophic factor in central nervous system

The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders

Research Progress on Neural Circuit Mechanisms of Depression

BDNF and Its Multirole Function in Neurogenesis, Synaptic Transmission and Neurodegenerative Diseases

New Insights into BDNF Function in Depression and Anxiety

Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes

Neuroplasticity and the Biological Role of Brain Derived Neurotrophic Factor in the Pathophysiology and Management of Depression

Research progress on the relationship between brain-derived neurotrophic factor and neural degenerative diseases

BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions

Targeting brain-derived neurotrophic factor in the treatment of neurodegenerative diseases: A review

Neural Plasticity and Depression Treatment

BDNF and synaptic plasticity, cognitive function, and dysfunction.

Progress of Receptors, Cytokine and Signal Pathways about Depression

Role of BDNF in the pathophysiology and treatment of depression: Activity‐dependent effects distinguish rapid‐acting antidepressants

BDNF signaling in context: From synaptic regulation to psychiatric disorders

Research progress of neurobiochemical mechanism of depression